Usefulness of an HIV DNA resistance genotypic test in patients who are candidates for a switch to the rilpivirine/emtricitabine/tenofovir disoproxil fumarate combination
Lambert-Niclot, S., Allavena, C., Grude, M., Flandre, P., Sayon, S., Andre, E., Wirden, M., Rodallec, A., Jovelin, T., Katlama, C., Calvez, V., Raffi, F., Marcelin, A.-G.Language:
english
Journal:
Journal of Antimicrobial Chemotherapy
DOI:
10.1093/jac/dkw146
Date:
May, 2016
File:
PDF, 169 KB
english, 2016